Chronic Kidney Disease (CKD) represents a significant global health burden, particularly due to its close association with cardiovascular disease (CVD). Patients with hypertension or diabetes are at a heightened risk of "Rapid Kidney Function Decline" (RKFD), a condition linked to increased mortality and heart failure. While many existing models focus on predicting the onset of CKD in healthy individuals, they often lose utility once a patient already has mild kidney impairment. This research presents a practical clinical tool—a nomogram—designed to predict the 5-year risk of RKFD specifically in populations already at risk for cardiovascular disease.
Methodology and Data
The study utilized an ambispective cohort design, analyzing data from 8,455 subjects who underwent community annual health examinations in Guangzhou, China, between 2015 and 2020. Participants included individuals aged 65 or older, or those aged 35 and older with existing diabetes or hypertension.
The primary endpoint, RKFD, was defined as a reduction in the estimated glomerular filtration rate (eGFR) of 40% or more during the follow-up period. To develop the predictive model, the researchers randomly assigned participants to a development cohort (n = 5,645) and a validation cohort (n = 2,810). Cox regression analysis and a backward stepwise approach were employed to identify the most significant clinical predictors from a wide array of laboratory and demographic variables.
A Practical Tool for Risk Assessment
The final predictive model was distilled into a graphical nomogram. This tool allows clinicians to assign points based on five readily accessible clinical markers: age, baseline eGFR, hemoglobin levels, systolic blood pressure (SBP), and diabetes status. The cumulative score corresponds to a specific 5-year probability of experiencing a rapid decline in renal function.
Key Results and Validation
During a median follow-up period of 3.72 years, the incidence of RKFD was approximately 12% across the entire cohort. The nomogram demonstrated robust predictive power, achieving an Area Under the Curve (AUC) of 0.763 in the development cohort and 0.740 in the validation cohort.
Crucially, the study identified a total nomogram score of 150 as an optimal threshold for risk stratification. Patients scoring above 150 were classified as "high-risk," with a 47.98% chance of rapid decline over five years, compared to just 11.90% for those in the "low-risk" group (score ≤ 150).
Clinical Insights
Several key insights emerged from the modeling process:
- The "Big Five" Predictors: The selection of age, eGFR, hemoglobin, SBP, and diabetes ensures the tool is highly applicable in primary care settings where advanced biomarkers may not be available.
- The Significance of Hemoglobin: Lower hemoglobin levels (anemia) were identified as a significant independent risk factor for RKFD, likely due to chronic hypoxia and oxidative stress within the kidneys.
- Personalized Metrics: By using a percentage-based decline (≥ 40%) rather than an absolute numerical drop, the model provides a more personalized assessment that accounts for a patient's unique baseline health.
Limitations and Future Directions
While the nomogram is a powerful tool for early intervention, the authors acknowledge certain limitations. The dataset lacked baseline albuminuria (protein in the urine) data, which is a traditional marker of kidney damage and might have further enhanced the model's accuracy. Additionally, as the study was conducted on a South Chinese population, the nomogram requires external validation in other ethnic and geographic groups to ensure its global generalizability. Future research may also explore the integration of novel genomic data or biomarkers to further refine these predictions.
Summary updated